Overview

Founded in 2009, after more than 10 years of steady development, Shanghai Ouyi Biomedical Technology Co., Ltd. (hereinafter referred to as "Oebiotech") has grown into a group enterprise in the biotechnology field with three wholly-owned subsidiaries of "Jingzhun Biotech", "Luming Biotech" and "Qingdao Ouyi" and more than 600 employees. The company provides related technical services from basic research to drug target discovery, pharmacological efficacy and safety evaluation, disease molecular marker screening, pathogenic bacteria and drug-resistant bacteria traceability for customers in the field of life sciences and health-related research fields, as well as pharmaceutical, food and daily chemical enterprises, so as to accelerate the research and development process of customers and greatly enhance the value of customer research and development. The company has built a complete multi-omics testing service platform and a multi-omics joint big data analysis platform, providing genomics, transcriptome, epibiome, microbiome, proteomics, metabolomics and other full-omics testing services; In recent years, we have gradually achieved comprehensive advantages in single-cell sequencing technology, spatial multi-omics technology (spatial metabolomics, spatial transcriptome), single-cell proteomics technology, and multi-omics joint analysis. In 2017, based on years of technology accumulation and precipitation in the field of multi-omics, it entered the field of molecular diagnosis, focusing on reproductive genetics, focusing on chromosomal genetic diseases, monogenic genetic diseases and infertility-related genetic diseases, building a closed-loop molecular diagnostic technology system and product system for birth defect prevention and control, and committed to eugenics and happy Chinese families. OKX has successively established close industry-university-research cooperation with Ocean University of China, Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences and other institutions, built a joint R&D laboratory with Hitachi Diagnostics Co., Ltd., and cooperated with East China Normal University to establish an academician expert workstation, and has successively obtained the qualifications of Minhang District R&D Institution, Minhang District Science and Technology Little Giant Enterprise, Shanghai Science and Technology Little Giant Enterprise and other qualifications. It has also obtained the qualification of intellectual property management system certification enterprise, with a total of 38 authorized invention patents, 48 invention patents under review, and 170 authorized software copyrights. "OKX" always adheres to the value concept of "hard data, good service", attaches great importance to data quality and customer service experience, constantly builds its own "service force", listens to customers' voices, cherishes customer entrustment, always takes customer satisfaction as the primary criterion for work quality evaluation, and strives to build an advantageous brand of "innovative multi-omics".